Salim I Khakoo Selected Research

KIR2DL3 Receptors

7/2011

A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salim I Khakoo Research Topics

Disease

15	Infections 01/2022 - 08/2004
9	Neoplasms (Cancer) 01/2022 - 08/2005
9	Virus Diseases (Viral Diseases) 01/2020 - 08/2005
6	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2019
5	Hepatitis C 01/2022 - 04/2010
3	Liver Diseases (Liver Disease) 01/2019 - 01/2018
2	Lymphoma (Lymphomas) 01/2022 - 01/2021
2	Chronic Hepatitis B 01/2019 - 04/2015
2	Viremia 07/2016 - 04/2010
1	Melanoma (Melanoma, Malignant) 01/2021
1	T-Cell Leukemia (Leukemia, T Cell) 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Non-alcoholic Fatty Liver Disease 06/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Human Influenza (Influenza) 01/2018
1	Chronic Hepatitis C 01/2017
1	Dengue (Dengue Fever) 01/2017
1	Yellow Fever 01/2017
1	Hepatitis B 07/2016
1	Communicable Diseases (Infectious Diseases) 02/2015
1	Carcinogenesis 01/2014
1	Persistent Infection 07/2011
1	HIV Infections (HIV Infection) 01/2011
1	Macular Degeneration (Age-Related Maculopathy) 11/2008
1	Vaccinia 01/2006
1	Autoimmune Diseases (Autoimmune Disease) 08/2005

Drug/Important Bio-Agent (IBA)

12	LigandsIBA 01/2021 - 08/2004
6	Peptides (Polypeptides)IBA 01/2022 - 09/2013
6	HLA-C Antigens (HLA-C)IBA 01/2021 - 11/2008
5	KIR ReceptorsIBA 01/2021 - 11/2008
5	HLA Antigens (Human Leukocyte Antigens)IBA 09/2013 - 08/2004
4	Natural Killer Cell ReceptorsIBA 01/2019 - 08/2004
3	Antiviral Agents (Antivirals)IBA 01/2018 - 10/2011
3	RNA (Ribonucleic Acid)IBA 01/2017 - 07/2011
2	obinutuzumabIBA 01/2022 - 01/2021
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2010
2	AntibodiesIBA 01/2021 - 07/2011
2	Interferon LambdaIBA 12/2020 - 11/2020
2	Interleukin-12 (IL 12)IBA 01/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 04/2010
2	nasIBA 01/2019 - 04/2015
2	CytokinesIBA 12/2011 - 11/2010
1	VaccinesIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	cyclopropapyrroloindoleIBA 01/2021
1	selinexorIBA 01/2021
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Hepatitis B e AntigensIBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Granzymes (Granzyme)IBA 01/2018
1	HLA-Bw4 antigenIBA 01/2017
1	micaIBA 07/2016
1	Genetic Markers (Genetic Marker)IBA 04/2015
1	tapasinIBA 09/2013
1	HLA-B Antigens (HLA-B)IBA 09/2013
1	Aspartic Acid (Aspartate)FDA Link 09/2013
1	Immunoglobulins (Immunoglobulin)IBA 08/2011
1	KIR2DL3 ReceptorsIBA 07/2011
1	Interferon-gamma (Interferon, gamma)IBA 04/2010
1	NK Cell Lectin-Like Receptor Subfamily CIBA 01/2006

Therapy/Procedure

7	Therapeutics 01/2022 - 04/2015
5	Immunotherapy 04/2022 - 01/2018
1	Duration of Therapy 01/2019
1	Ligation 01/2019
1	Withholding Treatment 04/2015